Health Condition 1: J452- Mild intermittent asthma
Conditions
Interventions
Intervention1: NEBULIZED SALBUTAMOL WITH HYPERTONIC SALINE: The child will be nebulized with salbutamol
(5mg/ml ) @ 0.15 mg/kg ( maximum - 5mg ) plus hypertonic saline - 3ml at 0 , 20 and 40 minutes
Sponsors
SHIVARAMAN P
Eligibility
Inclusion criteria
Inclusion criteria: Children with clinically diagnosed Asthma aged 6 years - 18 years presenting to pediatric OPD , Pediatric chest clinic with mild/moderate exacerbation as assessed by PRAM score
Exclusion criteria
Exclusion criteria: Pre-existing chest wall/ neuromuscular disease/ other pulmonary conditions such as CF, ILD, Bronchiectasis, PCD, etc. Children who received a short acting beta-2 agonist within 6 hrs Children who received a long-acting beta-2 agonist within 12 hrs Children not able to perform Spirometry. Children involved in any other trial. Repeated admissions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FEV1 measured before and at 60 minutes after nebulization.Timepoint: 0,20,40 and 60 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical severity score (PRAM) measured at baseline and at 60 minutes after nebulization.Timepoint: 0,20,40 and 60 minutes;Other Spirometry parameters (PEFR; MMER) measured at baseline and at 60 minutes.Timepoint: 0,20,40 and 60 minutes | — |
Countries
India
Contacts
Public ContactRakesh Lodha
AIIMS NEW DELHI
Outcome results
None listed